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Abstract 
Background: Achalasia cardia is a motility disorder affecting the esophagus with loss 
of progressive peristalsis and deglutitive relaxation of the lower esophageal sphincter. 
The pathogenesis of the disease and its etiology is poorly understood. Laparoscopic 
Heller’s myotomy, pneumatic balloon dilatation of the lower esophageal sphincter and 
intra-esophageal injection of botulinum toxin are some of the treatment modalities 
available.    
Type of study: Prospective observational study  
Methodology:  Twenty one patients who underwent laparoscopic Heller’s myotomy 
were recruited for the study. Biopsy of the lower esophageal muscle was obtained and 
histopathological, immunohistochemical and ultrastructural analysis was performed. It 
was correlated with the clinical features, manometric features and post-operative 
outcomes.  
Conclusion: Achalasia cardia is an inflammatory disease of the myentric plexus with 
early onset of fibrosis and progressive neuronal degeneration affecting myelinated and 
non-myelinated neurons. Degree of fibrosis increases with the duration of illness. 
Degree of fibrosis of the lower esophageal sphincter or degree of inflammation in the 
myentric plexus did not affect the manometric features of dysphagia or post-operative 
outcomes. Selective inhibition of the inhibitory neurons and inciting factors are the 
facets of the disease which still remains an enigma.   
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                       Introduction  
Achalasia cardia is an inflammatory disease of unknown etiology which is 
characterised by failure of relaxation of the lower oesophageal sphincter and absence 
of progressive peristalsis in the lower oesophagus. These patients classically present 
with dysphagia to liquids more than to solids.  
There have been many theories regarding the etiology of the disease and the 
pathophysiology of the disease is poorly understood. There are various treatment 
options available of the disease such as balloon dilatation, Heller’s myotomy and 
botulinum toxin injection. Treatment with calcium channel blockers are also been 
tried.  
 
Relevance of the study:  
In view of the poor understanding of the pathophysiology of the disease and paucity of 
data in our country regarding the disease process and the clinical profile and outcomes 
of these patients, this observational study was performed looking at the 
histopathological, ultra structural, manometric features and to analyse the short term 
surgical outcomes after laparoscopic Heller’s myotomy. 
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              Aims and objectives  
Primary objective:  
 To study the histopathological , immunohistochemical and electron 
microscopic features of the esophageal muscle layer in achalasia cardia  
 
Secondary objective:  
 To assess the short term results after laparoscopic Heller’s myotomy procedure 
 To study the correlation between the histological features and the clinical 
symptoms, duration and severity of symptoms and symptom relief after 
myotomy. 
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                 Literature review  
Achalasia cardia is a esophageal motility disorder which is characterised by failure of 
relaxation of the lower oesophageal sphincter and absence of progressive peristalsis.    
This disease is a unique motility disorder with specific anatomical, functional and 
pathological characteristics.  With recent advances, the understanding of the symptom 
complex of this disease can be well understood and categorised.  However, the 
pathophysiology and the etiological factors affecting this disease still remains an 
enigma.   
Epidemiology:  
The incidence and prevalence of  achalasia is 1.63/100,000 and 10.82/100,000 in a 
Canadian based study(1). Incidence and prevalence in the United Kingdom was 
0.5/100,000 and 8/100,000(2).  Men and women are equally affected. It is common 
between the ages and 25 and 60 years but can be seen at any age. There is no Indian 
data available for incidence and prevalence of this disease.  In a Lucknow based study 
on the spectrum of causes for motor dysphagia, 77% of the subjects were diagnosed to 
have achalasia(3). 
Classification: 
Achalasia is a primary motor disorder of the oesophagus and it can be classified as 
primary or idiopathic if the etiology is unknown and secondary if it is a part of the 
symptom complex of diseases like sarcoidosis, dermatomyositis, amyloidosis, 
Chaga’s disease and cancer in the gastro-esophageal junction.  Pseudoachalsia is the 
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term used to when it associated with pancreatic pseudocyst around the distal 
esophagus.  Features of gastro-esophageal junction narrowing and proximal dilation is 
seen in barium swallow but the manometric features are not diagnostic of achalasia.(4) 
Symptoms:  
The most common symptom of achalasia is dysphagia.  It is more to liquids in the 
initial stages of the disease. Dysphagia improves sometimes with valsalva manoeuvre.  
Regurgitation occurs as there is usually a large volume of retained food and saliva. It 
is precipitated by recumbent position and it can be complicated by aspiration 
pneumonia.  Chest pain in another infrequent symptom associated with achalasia. It 
can mimic ischemic heart disease. Heart burn like symptoms is also noticed and this 
symptom need to be differentiated from GERD as gastro-esophageal reflux rules out 
achalasia. One possible explanation of heart-burn like symptom could be due 
formation of lactic acid secondary to fermentation of the retained food particles in the 
lumen(4). Weight loss is usually modest and if it is pronounced, there should be a high 
index of suspicion for a malignancy of the gastro-esophageal junction causing 
secondary achalasia.  
For assessment of symptom complex following therapeutic intervention, different 
scoring systems are formulated.  Mellows and Pinkas scoring system(5) and Eckardt 
scoring systems(6) were commonly used.  
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Table 1 : Mellows and Pinkas score   
 score  Dysphagia  
   0 Able to eat normal diet 
   1 Able to swallow some solids 
   2 Able to swallow only semi solids  
   3  Able to swallow only liquids  
   4 Unable to swallow anything  
 
 
 
 
 
 
Table 2 : Ekardt score    
Score  Weight loss  Dysphagia  Retrosternal pain Regurgitation 
     0 None  None  None  None  
     1 < 5 kg Occasional Occasional Occasional  
     2 5 – 10 kg Daily  Daily Daily 
     3  >10 kg Each meal Each meal Each meal  
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Understanding the pathophysiology of achalasia 
Achalasia cardia is a primary motility disorder affecting the lower esophagus. The 
hallmark of this disease is loss of deglutitive relaxation of the lower esophageal 
sphincter and absence of progressive peristalsis.  
The pathophysiology of this disease has been an area of research for long. Ironically, 
even with advances in science and technology this disease is still poorly understood. 
This can be further studied under the following headings. 
 Anatomy of esophagus and lower esophageal sphincter musculature 
 Enteric nervous system 
 Peristalsis of esophagus 
 Interstitial cells of Cajal 
 Histological features of achalasia  
 Etiology of achalasia  
 
Anatomy of esophagus and lower esophageal sphincter musculature : 
Esophagus is a muscular tube extending from the pharyngoesophageal junction to the 
esophago-gastric junction. It approximately 20cm in length and it can be anatomically 
divided into cervical, thoracic and abdominal esophagus.  It walls is made up of four 
layers, mucosa, submucosa, muscularis propria and adventitia. Unlike other parts of 
the gut, esophagus is devoid of serosa. The muscularis propria comprises an outer 
circular layer and an inner longitudinal layer.  The longitudinal fibres are arranged in 
three fasciculi, one ventral and two laterals. The three fasciculi combine as they 
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descend down to form the outer coat of the muscular layer. The inner circular layer is 
a continuation of the inferior constrictor muscle fibres and they run transversely in the 
upper part and obliquely in the lower esophagus. The circular layer in thicker than the 
longitudinal layer and it subsequently becomes a lower esophageal sphincter at the 
level of the gastroesophageal junction.  The upper third of the esophagus is derived 
from the mesenchyme of the foregut and it of striated muscle fibres.  The middle third 
is of a mixture of striated and smooth muscles and the lower third is comprised of 
smooth muscle.  
                               Lower esophageal sphincter is basically a modulation of the inner 
circular layer. It is basically a functional unit with intrinsic and extrinsic components. 
The intrinsic component is a modification of the esophageal musculature and the 
extrinsic component is the diaphragmatic crura. It was first described by Liebermann-
Meffert et al that some of the  fibres at the level of the gastroesophageal junction gets 
modified to semi-circular which are arranged obliquely(7).  They noticed two 
distinctive types of fibres, the sling fibres which run obliquely draping the cardia of 
the stomach at the greater curvature and the clasp fibres, arranged in the lesser 
curvature, with both ends of the fibres clasping and pulling both ends of the sling 
fibres.  This is further confirmed with simultaneous measurement of endoscopic 
ultrasound and manometer  and contributions of the individual components of the 
lower esophageal sphincter(8).  Thus the clasp and sling fibres, the diaphragmatic 
crura and the lower circular smooth muscle are the chief contributors to the high 
pressure of the lower esophageal sphincter(8,9).   
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Figure 7:sling and clasp fibres (courtesy - Liebermann-Meffert;Gastroenterology 
1979)  
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Nervous system of the lower esophagus:  
To study the nervous system of the esophagus, it is essential to understand its 
embryological origin.  Esophagus is derivative of foregut and is initially develop as a 
small diverticulum, called the tracheobronchial diverticulum.  By 4 weeks of 
gestation, the neural crest cells migrate the foregut cranio-caudally. At 6 weeks of 
gestation, smooth muscles differentiation begins and the neural cells subsequently 
develop and by 7 weeks of gestation, the myentric plexus is formed. Then the neural 
crest cells begin to centripetal migration through the circular muscle layer resulting in 
the formation of sub-mucosal plexus. By 14 weeks of gestation, another network of 
neuronal cells forms a network surrounding the myentric plexus which is known as 
the interstitial cells of Cajal. They are also called gut- pacemaker cells as they are 
observed to have a key role in the neural transmissions within the gut(10,11). 
                                        The upper third of the esophagus is comprises of striated 
muscle and they are derived from the 4
th
,5
th
 and 6
th
 branchial arches and consequently 
they are supplied by the vagus. The lower third of the esophagus has a complex neural 
circuits and the embryological origin of the lower esophageal sphincter is still not 
clear.   
                                     Sensory innervation of the esophagus is by the sympathetic and 
the parasympathetic and motor innervation is primarily the parasympathetic i.e. the 
vagal nerve.  The vagal nerve afferents mechano-sensitive and conduct stimuli such as 
pressure and tension and transduce them to pain sensations.  The sympathetic (spinal) 
afferents are situated in the epithelium and they are chemo-sensitive. They conduct 
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stimuli from luminal acid and transduce them to pain sensations.  In achalasia, there is 
decreased sensation to distension and acid sensation thus proving that they have 
decreased chemo-sensitivity and mechano-sensitivity(12).  This should mean that 
these patients should have less pain, but chest pain is one of the well documented 
symptoms of achalasia.  In one proposed theory, the tertiary esophageal contractions is 
the reason behind pain. Other possible reasons could be chronic irritation of the 
mucosa by retained food particles or fungal/bacterial overgrowth resulting in 
inflammation. 
  
                 The motor supply of the esophagus is primarily by the vagus nerve. The 
impulses originate from nucleus ambiguous and dorsal motor nucleus. They interact 
with the ganglion cells in the myentric plexus of Auerbach. These ganglion serve as 
interneurons between the vagus and the smooth muscle(13).     
 
Peristalsis of the esophagus :   
Esophagus is a muscular tube connecting the pharynx to the stomach. It basically 
serves as a transit for food bolus.  Swallowing is an intricately co-ordinated reflex 
action of the muscles of the pharynx and the neck. Various phases of deglutition 
include the oral phase, pharyngeal phase, esophageal phase. Initiation of swallowing 
reflux result in  relaxation of the upper esophageal sphincter. Almost immediately 
after the food transits the upper esophageal sphincter, it closes to prevent retrograde 
motion of the food. The food bolus pushed down the esophagus by smooth peristaltic 
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wave staring from the pharynx till it is emptied into the stomach. There are three types 
of peristalsis.  
 Primary peristalsis:  Peristaltic wave is generated in response to food. The 
rate of the peristaltic wave is 4cm per second and it takes about 10 to 15 
seconds for completion of one peristaltic wave.  The strength of contraction is 
highest in the lower esophagus corresponding to the smooth muscles and 
lowest in the transition zone corresponding to the mixture of smooth and 
striated muscle fibres.  This phase is carried on by two important process. 
Peristaltic wave aborally and relaxation of the lower esophageal sphincter.  
 Secondary peristalsis: Usually there is no residual food in the esophagus 
following a primary peristalsis. But if there be any residual food particles 
following an ineffective peristalsis, it is cleared up by the secondary 
peristalsis.  Unlike primary peristalsis, only the segment of esophagus distal to 
the residual food in involved and there is no relaxation of the upper esophageal 
sphincter.  
 Tertiary contractions: This used to refer to the non- peristaltic contractions 
noted in barium study. This terminology is no longer in use.  
Mechanism of esophageal contraction :  
Central control of peristalsis :     
            As seen earlier, the esophagus is innervated by the parasympathetic and the 
sympathetic nerves. The parasympathetic control is by the vagal nerve fibres which 
originate from the Dorsal Motor Nucleus (DMN). These are myelinated pre-
ganglionic fibres contained with acetylcholine neurotransmitter. There fibres synapse 
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with the neurons in the myentric plexus of Auerbach. The current understanding is 
that these neurons make direct contact with smooth muscle cells through the motor 
end plate. Excitatory and inhibitory function is based on the neurotransmitter 
produced at the nerve terminal.  Nitric Oxide (NO) and Vasoactive Intestinal Peptide 
(VIP) are inhibitory neurotransmitters.  Acetylcholine (Ach) and Substance P(SP) are 
excitatory  
neurotransmitter (14).  
 
 
Figure 8 : Motor innervation of the esophagus (courtesy – Nature : GI motility)         
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The striated muscle peristalsis is less complex as the central nervous system initiates 
and regulates the peristaltic wave with sequential firing of impulses. It is regulated by 
the Swallowing Generator Program(SPG)(14).  
                           
Peripheral control of peristalsis :           
The smooth muscle segment of the esophagus with its sophisticated enteric neural 
system can regulate a smooth peristaltic wave by itself without the regulation of the 
central nervous system(15).  It can also initiate a peristaltic wave secondary to local 
distension.   
 
Figure 9 : Latency gradient of contraction ( Courtesy – Nature : GI motility)  
               
                             As the peristaltic wave passes the striated muscle and reach the 
smooth muscles segment the peristaltic wave is induced unlike in the striated muscle 
segment. A period of latency can be noted as duration between the stimulus and onset 
of contraction progressively increases aborally. This is called ‘latency gradient’ of 
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contraction. It is proven that there is an initial inhibitory wave conducted distally prior 
to the peristaltic wave. Thus the smooth muscle cells are initially hyperpolarised. 
There is difference in the duration of depolarisation and this duration progressively 
increases aborally(16,17). This difference could theoretically explain the delay in the 
onset of contraction as seen in the figure. However animal studies done based on this 
theory has proven that the peristalsis is vivo is much slower than the theoretical 
calculations. Thus, must be a mechanism other than the intrinsic latency gradient to 
explain this phenomenon. Another proposal is that a secondary inhibitory wave 
precedes depolarisation and it is regulated by intramural descending inhibitory 
pathways (15).  In animal models it had been proven that this descending reflex is 
mediated by nitric oxide(18).    
 
   
Figure 10 : Distribution of cholinergic and Non- cholinergic fibres (courtesy – Crist et al. PNAS 1984)  
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Another feature explaining this latency period is the unequal distribution of 
cholinergic and the nitriergic nerve fibres in the esophagus. The cholinergic 
innervation is predominant in the upper esophagus but its gradient gradually decreases 
in the lower esophagus and vice versa for nitriergic fibres(14) 
In achalasia, there is absence of progressive peristalsis. It is clear that progressive 
peristalsis is a complex process which is tightly regulated by the enteric nervous 
system and the primary defect in achalasia is attributed to loss of inhibitory neurons.   
 
Degluttive inhibition of peristalsis:   
When the bolus of food enters the esophagus at intervals more than 10 seconds, then it 
can respond to one-on-one basis with relaxation of lower esophageal sphincter and 
then propulsion of the food bolus to the stomach. However, in reality, the food bolus 
enters at a rate faster than 10 seconds ( eg. Drinking water in rapid succession). In 
such instances the phenomenon of deglutitive inhibition comes to play. Once the 
esophagus senses multiple food boluses entering at rapid succession, it halts all 
contraction and the esophagus becomes aperistaltic transiently to accommodate the 
incoming food bolus. During this time period, the lower esophageal sphincter remains 
open. After the entry of all the food boluses, then the peristalsis resumes in order.  
 
Lower esophageal sphincter relaxation :   
It is the distal most part of the esophagus with a zone of high pressure even at resting 
state. Various factors are attributed to the resting high basal tone of the LES.  
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Myogenic tone is increased as the LES sphincter has increased proportion of alpha –
actin in comparison to the esophagus.  The muscles cells even at resting state have 
spontaneously opened chloride channel. This maintains a depolarised state with 
constant influx of calcium ions. Relaxation of LES begins with 2 seconds of relaxation 
of the UES. As the food bolus reaches the LES, it elongates and effaces forming an 
ampulla. Following the transit of the bolus it immediately contracts and the LES 
pressure remains higher than the intra-gastric pressure, till the next wave of peristalsis.  
 
Interstitial cells of cajal :   
Interstitial cells of Cajal, otherwise known as pacemaker cells of the gut. As explained 
earlier, they are situated in the myentric plexus of Auerbach.  Peristalsis in the smooth 
muscle is a sophisticated mechanism involving the central nervous system and the 
intrinsic nervous system. Descending inhibitory reflex in an important phenomenon 
which enables smooth propagation of peristalsis.  These complex neural transmissions 
are thought to be modulated by the interstitial cells of Cajal.  As of now, it is 
understood that the post ganglionic nerve fibres release neurotransmitter which 
directly act on the muscle fibres. However, now there are evidence pointing towards a 
system where the post-ganglionic fibres synapse with the interstitial cells of Cajal 
which in turn relays the impulse to the smooth muscles(19). 
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 Figure 11: Relation of interstitial cells of Cajal, enteric nervous system and smooth muscles 
 
    
 
 Histology of achalasia :   
As it is evident that the primary pathology is absence of progressive peristalsis and 
failure of relaxation of the lower esophageal sphincter, histopathological studies are 
conduction in a few centres worldwide. Goldblum et al has the largest series of 
histopathological studies done in 42 patients who underwent esophagectomy for 
achalasia. He noticed loss of ganglion cells were noted in 52% of the specimens.  It 
was associated with various grades of inflammation and fibrosis which brought to the 
supposition that the inflammation occurred early in the natural history of the 
disease(20).  Smooth muscle cell hypertrophy was also noted.  It was attributed to the 
loss of nitriergic inhibitory neurons which was confirmed in experiment studies on 
NO synthase knocked out mice with similar recordings (21).  Electron microscopic 
studies have suggested have suggested increased in eosinophil in achalasia and the 
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retained food debris resulting in mucosal injury was attributed for the increased 
antigen exposure.  Interstitial cells of Cajal have been noted to be in close proximity 
of the myentric plexus neurons and immunohistochemical analysis have shown 
decrease in c-kit expression suggesting a probable primary pathology of the interstitial 
cells of Cajal.    
 
 
 
Etiology of achalasia :  
 There is no one proven etiological factor for this disease. In fact all the treatment 
modalities aimed at this disease are palliative in nature as we do no treat the primary 
pathology. Pathological process in the central nervous system or extrinsic neural loss 
as the primary pathology is ruled out as there is no consistent evidence in case reports 
and also in experimental studies. Intrinsic loss of neurons secondary to inflammation 
was considered.  The following are some of the theories proposed: 
1. Inflammatory secondary to viral infection:  Only measles virus association was 
proven to be statistically significant in studies, however the causal relationship 
could not be ascertained.  
2. Chronic obstruction: This was thought to be the reason for long as many 
patients with obstruction at the gastroesophgeal junction loss peristalsis and in 
some of them when the obstruction is relieved via a myotomy, peristalsis 
regained. This theory was tested in animal models with moderate success.  
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3. Chronic neuronal degeneration: This was proposed as there were case reports 
of Parkinsonism associated with dysphagia. Interestingly, both achalasia and 
Parkinsonism patients with dysphagia had increased Lewy body deposition. 
But the manometric findings of these patients were not as that of achalasia.  
4. Familial : It was thought to be an autoimmune disease due to the following 
features 
(i) Anti-myentric  IgG antibodies were noted to be significantly 
increased in achalasia (22). 
(ii)  Increased inflammatory cells infiltration was noted in around the  
myentric plexus region as evidenced by electron microscopic and 
immunohistochemical analysis(23) 
(iii)  Increased prevalence of HLA class II antigens(24).  
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                               Evaluation 
In patients suspected to have achalasia, further evaluation is required to confirm the 
diagnosis. Manometry is diagnostic for achalasia. Barium esophagogram is indicated 
if the manometry is inconclusive.  Upper gastrointestinal scopy should be done in 
patient suspected to have secondary achalasia.  
Manometry:   
It is the gold standard for diagnosis of achalasia cardia. There are two types of 
manometry. There are two types of manometry. 
A ) Conventional manometry:  
Characteristic feature of achalasia in conventional manometry is absence of relaxation 
of lower esophageal sphincter and aperistalsis.(25)   
 Basal lower esophageal sphincter pressure falls in response to swallow. 
Normally it falls to a level of 8mmhg above the gastric pressure.  If the basal 
lower esophageal pressure remains >8mmhg above the gastric pressure, it is 
diagnostic of achalasia.  
 Aperistalsis is noted in the distal 2/3rd of the esophagus. Even though there may 
be minimal pressurisation in response to swallow, they are non-sequential with 
amplitude less than 40mmHg. 
 
B) High Resolution  Manometry (HRM) 
In contrast to conventional manometry where sensors are spaced at 3 to 5 cm 
intervals, HRM sensors are typically spaced 1 cm apart along the length of the 
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manometric assembly. Catheters with up to 36 sensors distributed longitudinally and 
radially in the esophagus allow for simultaneous pressure readings spanning both 
sphincters and the interposed esophagus.  Esophageal pressure topography (EPT) is a 
three-dimensional plotting format devised for depiction of HRM studies.  EPT 
interpolates pressure values between sensors to create a pressure continuum.  Pressure 
magnitude is converted into a color scale using ‘cold’ colors to denote low pressures 
and ‘hot’ colors to denote higher pressures. 
 
Figure 1 : High resolution manometry (Courtesy – uptodate - HRM) 
The result is a seamless isobaric contour (IBC) map spanning from the upper 
esophageal sphincter to the esophagogastric junction (EGJ). This also allows for the 
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depiction of real-time luminal pressure gradients and spatial transition points of 
contraction amplitude or propagation velocity along the esophagus that correlate with 
anatomical and  physiological landmarks.(26)     
 
Analysis of the HRM includes the following:  
Contractile segments:  
Topography of HRM shows four contractile segments.(27)  
First contractile segment                    : Upper esophageal sphincter contraction . 
Second and third contractile segment: Contraction of the body of the esophagus 
Fourth contractile segment                 : Lower esophageal sphincter  
 
Transition zone:  
 A pressure trough noted between the 1
st
 and 2
nd
 contractile segment which is labelled 
the "transition zone"(28).   This is also identified as the region of transition of 
neurological control. Proximal to this zone, the peristalsis is controlled by the central 
nervous system and distal to this zone the control of peristalsis is taken over by 
intrinsic nervous system(29).  
 
Contractile deceleration point (CDP) : 
The velocity of contraction is rapid in the proximal esophagus corresponding to the 
rapid transit of food bolus. At a certain near the esophagogastric junction, the velocity 
and the propagation of the food bolus slows down. This marks the onset of formation 
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of the phrenic ampulla, a distinct feature of the lower esophageal sphincter which 
transiently becomes effaced and elongated(30).  (Figure 5) 
 
 
Figure 2 : Contractile deceleration point (CDP)  (Courtesy –Uptodate –HRM) 
 
Integrated Relaxation Pressure :   
Normally, the lower esophageal sphincter relaxes in response to a swallow to facilitate 
passage of food bolus.  Absence of relaxation of the LES is expected in achalasia 
which is translated as raised intraluminal pressure in the manometry.  Raised 
intraluminal recording could be due to a confounding factor such as an external 
compression from the crural diaphragm.  As it is not possible to distinguish between 
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external compression and impaired relaxation of the lower esophageal sphincter based 
on the pressure readings, a complex metric, known as the integrated relaxation 
pressure is formulated.   
 
    Figure  3 : Integrated Relaxation Pressure  (Courtesy : Uptodate – high resolution 
manometry) 
 
  Time in seconds is plotted at the x- axis and the pressure on the Y-axis (figure 6). 
Following upper esophageal sphincter relaxation,  a time window of 10 seconds is 
considered. In this time window, a four second the time frame of esophagogastric 
junction relaxation was noted (contiguous or non-contiguous).  The LES pressure 
during this  period of relaxation was calculated and its mean is recorded as IRP. 
Basically, it is defined as the average minimum pressure at the esophagogastric 
junction for four seconds of relaxation within 10 seconds of swallowing (upper 
sphincter relaxation).   The upper limit of normal IRP is 15mmhg (31).  
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Contraction :  Any lumen obliterating pressure recorded in the manometry is called 
contraction. Basically, the circular smooth muscle layer constricting down the 
pressure transducer.    
 
Pressurisation: This denotes the pressure recorded within an open; for example 
between closed upper and lower esophageal sphincter. It is represented as a vertical 
band in the topography of the HRM (32).   
 
Based on  the HRM, achalasia is classified into three types(33). 
 Type I – Median IRP >upper limit of normal, 100 percent failed peristalsis, 
minimal pressurization within the esophagus. 
 Type II – Median IRP >upper limit of normal, no normal peristalsis, pan-
esophageal pressurization with ≥20 percent of swallows. 
 Type III – Median IRP >upper limit of normal, no normal peristalsis, preserved 
fragments of non-propagating distal peristalsis.  
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Figure 4: Chicago classification of achalasia(courtesy: Annals of Gastroenterology  
(2015) 
 
 
Imaging:  Barium esophagography 
As manometry is diagnostic of achalasia, Barium study is not indicated in all patients.  
Barium esophagogram may be falsely negative in 30% of the cases(34). In earlier 
stages of the disease, narrow esophagogastric junction seen as bird-beak appearance 
and aperistalsis can be seen.  In advanced cases, significantly dilated and tortuous 
esophagus described as mega-esophagus or sigmoid esophagus is noted.  Occasional 
sudden burst of peristaltic activity can be seen and it is described as Hurst 
phenomenon.    
Imaging: Chest X ray  
Dilated esophagus can be seen as widening of the mediastinum with absence of fundic 
air bubble. 
35 
 
 
 
Upper gastrointestinal scopy:  
Esophageal mucosa remains normal in achalasia. Due to stasis of food, esophageal 
candidiasis can be noted occasionally.  Lower esophageal sphincter is usually 
occluded and it does not open spontaneously as in normal individuals. However, the 
scope can be easily negotiated through the lumen with a gentle push and a 
characteristic ‘give’ can be experienced by experienced endoscopists.  Upper 
gastrointestinal scopy is more relevant if there is a suspicion of malignancy causing a 
secondary achalasia.  
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Management of achalasia:  
Achalasia has been known to mankind for more than 300 years.  In 1674, Sir Thomas 
it was treated by dilatation of the esophagus using whale bone.  Treatment approaches 
have evolved over the years. Currently the options available are medical, minimally 
invasive and surgical.   
I) Pharmacological therapy:  
Relaxation of the lower esophageal sphincter using  pharmacological agents such as 
nitrates(isosorbide dinitrate 5mg) and calcium channel antagonists(nifidipine 10mg to 
30mg) have been tried with unsatisfactory results(35).  It is also associated with 
significant side effects like headache, hypotension. Eventually tachyphylaxis occurs 
rendering it useless. Other drugs like 5-phosphodiesterase inhibitors (sildenafil), 
anticholinergics (dicyclomine) and beta adrenergic agonists (terbutaline) have been 
tried but there is no evidence to prove its efficacy. It can be however used as mode of 
treatment when the patient is not fit for operation or pneumatic dilation or while being 
evaluated or waiting for definitive management of achalasia(36).  
II) Minimally invasive management:    
Two most widely utilised modes of minimally invasive techniques are pneumatic 
dilatation and botulinum toxin injection.  
A ) Pneumatic dilatation :   
Principle:   
Dilatation of the lower esophageal sphincter results in stretching of the muscle fibres 
thereby decreasing the pressure.  Initially it was practiced using bougies and the 
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dilators have evolved over the years from mechanical dilators, to hydrostatic and of 
late pneumatic balloon dilators.   
Technique:     
Dilatation is done under anaesthesia or conscious sedation. There is still controversy 
and varied opinion among experts regarding the pressure to be used, rate of dilatation, 
duration of initial dilatation and number dilatations. However the most commonly 
practiced method is identification of the LES using manometry and then 120mL of air 
at a pressure of 7 psi for a duration of 60 seconds followed by rapid release of 
pressure.   
Outcomes:  
Short term relief of dysphagia is as high as 85% following pneumatic dilatation(37).  
However, the long term results were not as promising as the short term benefits. This 
is proven in a prospective study for 18 years in a single centre.  They noticed relapse 
rates were 18% by 2 years; 41% by 5 years and 60% by 10 years. Moreover, 43% 
patients underwent additional treatment such as repeat pneumatic dilatations and 
myotomy(38). 
 B) Botulinum toxin injection: 
Intra-sphincteric injection of botulinum toxin injection has been a practiced for 
treating achalasia. It is a type A botulinum toxin derived from clostridium botulinum. 
It inhibits acetylcholine from the nerve endings thereby resulting in reduction in LES 
pressure(39).  The short term effects are comparable with pneumatic dilatation or 
myotomy(40), however, the effect wane of within months requiring repeated 
injections within 6 months of injection(41).  
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C) Per-Oral Endoscopic Myotomy (POEM): 
This is a new technique where natural orifice is utilised for the operation (Natural 
orifice trans-luminal endoscopic surgery).  Short term results reveal its efficacy up to 
90% in relieving symptoms. There are not enough evidence regarding long term 
outcomes to recommend this treatment modality(42,43).  This safe and effective 
procedure. Studies done revealed good short term outcomes of dysphagia relief  and it 
is comparable with laparoscopic Heller’s myotomy(44). Acid reflux is however noted 
to be high after endoscopic myotomy(45).   
 
III) Surgical management:    
Operative management of achalasia was first described by Ernst Heller in 1913.  He 
described a double cardiomytomy (anterior and posterior myotomy).  In 1923, it was 
modified to just an anterior cardiomytomy. Success rate was 90% to 95%. Principles 
of operative management would include the following. 
 Reduction in the LES pressure with adequate cardiomyotomy. 
 Prevention of gastroesophageal reflux in the post-operative period. 
 Prevention of scarred closure of myotomy site.  
 
Initially this was through thoracic approach. In 1991, thoracoscopic approach 
was introduced which resulted in decrease in the post-operative pain and the 
number of days of hospital stay.  Anti-reflux procedures were not 
recommended during that time as there were no evidence to support it (25,26).  
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Subsequently in the mid-1900s laparoscopic approach became popular for two 
reasons.  Firstly, gastric extension of myotomy was considered crucial to 
prevent post-operative dysphagia. Secondly, anti-reflux procedures can be 
following the myotomy. Thirdly, post-operative hospital stay was lesser in 
patients undergoing laparoscopic myotomy. Thus, laparoscopic modified 
Heller’s myotomy with fundoplication is the current treatment of choice for 
achalasia(40,46–50).   Robotic approach have been tried and the results showed 
statistically significant reduction in the mucosal perforation rate, however there 
was a strong suspicion of bias in these studies as the mucosal perforation rates 
following robotic surgeries were compared with the perforation rates of the 
laparoscopy myotomy done earlier in their learning curve(51).    
 Extent of myotomy:  Initially, a limited gastric myotomy was performed.  A 
retrospective analysis done in a centre in Washington revealed 80% of patients 
who underwent limited myotomy (0.5cm to 1cm) had pathological levels of 
acid reflux and 17% of them had symptoms of dysphagia. Extension of gastric 
myotomy 1.5 to 2.0 cm was done in these patients who presented with 
dysphagia following the initial surgery. Fifty percentage of them had improved 
results. Subsequently, the next four years, 1.5cm to 2.0 cm myotomy was done 
and which resulted in a 90% success rate, however, few had recurrence of 
symptoms.  Therefore a full 3cm was gastric myotomy was done(52).  The 
current recommendations by SAGES is at least 4cm of myotomy on the 
esophagus and 2cm on the stomach(53).  
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 Anti-reflux procedure:  This has been of concern and a matter of debate for 
long as there was conflicting opinion regarding performing fundoplication 
simultaneously during the myotomy.  Some believed that adding a wrap 
procedure would defy the primary intent of preventing dysphagia and other 
believed that adding a wrap procedure would improve the quality of life by 
reducing reflux symptoms following myotomy. 
 
 
Picture 21 : Dor fundoplication (courtesy- university of  Washington) 
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Picture 21 : Toupet fundoplication (courtesy – University of Washington) 
 
Figure 5: Toupet fundoplication (courtesy – University of Washington) 
 
Meta-analysis has shown statistically significant increase in reflux symptoms in 
patient who did not have a fundoplication. It also showed a statistically significant 
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reduction in the 24 hour pH levels in patient with fundoplication.  Though the need for 
anti-reflux procedure is well estabilished, it is still unclear as to which one is the best.  
Anterior 180 degree Dor fundoplication (figure 8) and posterior 270 degree Toupet 
(Figure 9 and 10) have statistically significant reduction in post-operative dysphagia 
when compared with a floppy Nissen’s 360 degree fundoplication. There is no 
significant difference in the reflux symptoms.  A meta-analysis comparing Dor and 
Toupet fundoplication revealed no statistically significant difference in terms of acid 
reflux or dysphagia(54). Dor fundoplication is preferred by many surgeons as it 
requires lesser dissection at the gastro-esophageal junction. Also anterior wrap serves 
as a buttress if any repair of inadvertent mucosal injury is performed.  
Predictors of outcomes after myotomy : 
Several studies have looked into the predictors of poor outcomes but the results 
were not consistent. Some of the noted factors are the following(55,56). 
Positive predicting factors:  
1. Achalasia type II. 
2. Younger age (<40 years). 
3. LES pressure more than 30mmHg. 
Negative predicting factors:  
1. Severe pre-operative dysphagia. 
2. Low pre-operative LES pressure (<30mmHg). 
3. Sigmoid esophagus. 
4. Balloon dilation before myotomy. 
5. Botulinum injection before myotomy. 
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6. BMI > 30 
 
Treatment options following failed operation:  
                Failure rates after a myotomy is less, nevertheless when symptoms occur, it 
can be managed with botulinum toxin injection with a success rate of 71% in one year 
follow up. Other options are to do to redo laparoscopic operation which has 
satisfactory results.  Pneumatic dilatation following a failed myotomy is generally 
avoided as there is an increased risk of mucosal perforation. If symptoms of refractory 
after trying these modalities, then esophageal resection with gastric pull up is the only 
viable option(53) 
The following would summarize the treatment approach to achalasia cardia (57) 
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The following is the algorithm for management of achalasia cardia .   
 
 
Figure 6 : Annals of Gastroenterology (2015) 
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Methodology 
Setting:   
This study was conducted in the department of Surgery, unit III, Christian Medical 
College Hospital, and Vellore.  It was done in collaboration with the Institute of 
Pathology. 
 
Study design:  
This was a prospective observational study performed on patients undergoing 
laparoscopic Heller’s myotomy between October 2012 to September 2014  
 
Institutional review board and ethics committee approval: 
The study design and the methodology was assessed by the institutional review board 
and the ethics committee and duly approved. The copy of the approval form is 
enclosed (Appendix 1) 
 
Consent:  
Patients diagnosed with achalasia were invited to take part in the study and the 
informed consent was presented in the native language. The consent forms used in the 
study was enclosed. (Appendix 2)  
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Inclusion criteria:  
All patients who underwent laparoscopic Heller’s myotomy during the study period 
who have consented to take part in the study were included.  
 
Data collection:  
The following was obtained from each patient. 
1.  Demographic profile of the patient 
2. Preoperative dysphagia score 
3. Preoperative investigations including barium study, endoscopy, HRM 
4. Histopathological and immunohistopathological features of the 
oesophageal muscle biopsy 
5. Electron microscopic features  
6.  Achalasia is classified based on high resolution manometry 
7. Relief of dysphagia using dysphagia score  
 
Sample size: 
As this is an observational study, the sample size was based on the frequency that the 
procedure is being performed in our centre. A minimum sample size of 15 was 
planned.   
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Method of data collection: 
Surgical procedure:  
 All the patient were diagnosed with pre-operative manometry and barium study 
and taken up for the operation.  
 Laparoscopic modified Heller’s myotomy was performed. Entry was by four 
port technique.This involves dissection of the the connective tissue at the level 
of the esophageal hiatus followed by myotomy. It was extended up to 5cm in                            
 
 the esophagus and 2cm onto the cardia. It is done meticulously to avoid perforation of 
the esophageal mucosa. The only additional procedure performed in these patients was 
Specimen  A  
Specimen B 
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taking two small bits (0.5cm x 0.5cm each) of  oesophageal muscle from the cut ends 
of the myotomy. If leak is encountered, it was primarily repaired with 5-0 
polydiaxonine stiches.  Anterior fundoplication was done irrespective of mucosal 
injury.  Leak test or intra-operative endoscopy was not routinely performed. Drains 
were not usually placed.  
 
 The specimen obtained is checked for cautery artefact on microscopic 
examination.  As the sample obtained from the first patient revealed cautery 
artefact, the technique of obtaining the biopsy was modified to get a good 
quality tissue for the study.  Standard myotomy was done using the cautery.  
The proposed site of biopsy was chosen and the muscle tissue was gently 
grasped and dissected using scissors.  By doing this, we have one end of the 
muscle which does not have cautery effect.  The specimen is put on a 
dissecting slab and the cut end of the muscle is carefully chosen and sent for 
further examination.   
 The specimens obtained from the lower esophagus and the gastro-esophageal 
junction was labelled sample A and sample B respectively.  
 The specimens thus collected were preserved in 3% gluteraldehyde and 10% 
formalin for Electron microscopic studies and Histopathology studies, 
respectively. 
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Processing of sample for electron microscopy:  
1. Second fixation with 1% osmium tetroxide for additional stability during 
electron bombardment and decreases distortion. 
2. It is degraded in series with ascending strength of alcohol. 
3. Infiltrated by propylene oxide and eposy resin. 
4. Embedded in siliconised rubber mould with epoxy resin. 
5. Polymerisation is achieved by incubating the embedded mould at 60 degree 
for 48 hours 
6. One micron thin sections cut through ultra-microtome (Leica ultra-cut 
UC7) with glass knife and stained with toluidine blue.  It is further viewed 
in light microscopy which is called the one-micron study.  The areas of 
interest are marked out for ultrathin  microtome. 
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Picture 1: Leica EM UC7 microtome 
7. Ultrathin sections were cut using a diamond knife. These sections are taken 
on copper grid and stained with uranyl acetate and Reylon’s solution. 
8. Philips Tecnai electron microscope used in this study.  
                 
    Picture 2:  Diamond diatome use for cutting ultrathin section. 
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Picture 3: Philips Tecnai – Transmission Electron Microscopy. 
 The specimen used for histopathology is stained with haematoxylin and eosin 
to study the ganglion cells and inflammatory infiltrate.  The slides were coded 
and kept for immunohistochemistry analysis using CKIT (CD 117) , the 
marker which is specific for Interstitial Cells of Cajal(ICC of the gut)  and 
CD3, a marker of T lymphocytes. 
 The histopathological features were graded by the pathologist. Ganglion cells 
were identified and quantified as 3 groups. “Rare, Few and Many”.  
“Rare” indicates the presence of occasional cells,  
“Few” indicates the presence of infrequent cells and  
“Many” indicates the presence of numerous cells.   
Fibrosis was graded as Mild, Moderate and Severe.   
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Follow up:         
 Post-operatively, these patients were monitored till discharge and followed up 
at 1 month, 3 months and 6 months in the surgery OPD. Patient who were not 
able to come for outpatient visits were followed up with telephonic interviews. 
The short term surgical outcomes including complications and relief of 
dysphagia were recorded.  Dysphagia was quantified using a dysphagia score: 
0-Able to eat normal diet / no dysphagia 
1-Able to swallow some solid foods 
2- Able to swallow only semi solid foods 
3-Able to swallow liquids only 
4- Unable to swallow anything  
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RESULTS 
 Twenty one patients were recruited for the study. Intra-operative biopsy was 
obtained from 18 patients. The biopsy was adequate and representative in 17 
patients. In one patient, the biopsy material was non representative.  In three 
patients, intra-operative biopsy could not be done due to intra-operative 
difficulty. These patients were excluded from the analysis of histological 
parameters. So analysis was performed on 17 Pts. 
 Haematoxylin and eosin staining and Electron microscopy study was done in 
samples obtained from the 17 patients. 
 The following features were studied: 
1. Ganglion cells 
2. Nerve bundle hypertrophy 
3. Muscle fibres 
4. Perivascular fibrosis 
5. Inflammatory cells  
 Immunohistochemistry analysis was done in samples obtained from 15 of the 
17 patients.  
 
 
 
 
54 
 
H & E staining, immunohistochemistry and electron microscopy: 
 H and E staining: 
1. Ganglion cells: 13/17 cases showed absence of ganglion cells. 4/17 cases 
had occasional ganglion cells.  1/17 case was excluded from the study as it 
showed only connective tissue. 
 
 
 
Picture 4 : Fibrosis of the myentric plexus   
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2. Nerve bundle hypertrophy: 3/17 cases showed mild hypertrophy. 7/17 cases 
showed moderate hypertrophy. 2/17 cases showed severe hypertrophy.3/17 
cases revealed normal nerve fibres.  In 3/17 cases nerve bundle could not be 
identified.    
  
Picture 2A : Hyper trophy of nerve bundle : cross-sectional view 
 
Picture 2B : Nerve bundle hypertrophy : longitudinal view 
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3. Muscle fibrosis: 8/18 cases showed mild fibrosis. 3/17  cases showed 
moderate fibrosis. 1/18 cases showed severe fibrosis. 3/17 cases showed no 
fibrosis. In 3/17 cases findings were inconclusive.   
 
Picture 4A : Fibrosis of smooth muscles – mild  
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Picture 4B : Fibrosis of smooth muscles – moderate 
 
 
Picture 4C: Fibrosis of smooth muscles – severe  
4. Perivascular fibrosis: 3/17 cases showed mild fibrosis. 2/17 cases showed 
moderate fibrosis. 1/17 cases showed severe fibrosis.  8/17 cases showed no 
evidence of fibrosis. 
5. Inflammation: There was no evidence of significant inflammation in any of 
the cases.   
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IMMUNOHISTOCHEMICAL ANALYSIS: 
1. Inflammatory cells: They were found to be rare in 6/15 cases,  
Few cells were found in 2/15 cases and Many was found in 1/15 cases. 
They were absent in 2/15 cases. They were inconclusive in 4/15 cases.     
 
    
Picture 5A : Inflammatory cells - Rare 
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Picture 5B : Inflammatory cells – Few   
 
Picture 5B : Inflammatory cells – Many  
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2. Interstitial cells of Cajal:  They were rare in 3/15 cases, few in 1/15 cases 
and many in 5/15 cases, absent in 3/14 cases.  3/15 cases had inconclusive 
report.   
 
Picture 6A: Interstitial cells of Cajal - Rare 
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                     Picture 6B: Interstitial cells of Cajal - Few 
  
 
              Picture 6C: Interstitial cells of Cajal – Many               
3. Mast cells: They were rare in 5/15 cases, few in 1/15 cases, many in 3/15 
cases and absent in 3/15 cases.       
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          Picture 7: Mast cells. 
 
           ONE MICRON STUDY:  
1. Ganglion cells:  They were absent in all the cases.  
  
Picture 8 : One micron view of normal myentric plexus 
 
Picture 10 : One micron view of loss of ganglion cells in myentric plexus  
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2. Perineural fibrosis:  It was absent in 2/17 cases. There was mild fibrosis in 
11/17 cases, moderate fibrosis in 2 /17 cases and severe fibrosis in 1/17 
cases. 1/17 was inconclusive.   
 
Picture 11: Perineural fibrosis 
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3. Muscle fibrosis:  There was mild fibrosis in  2/17 cases, moderate fibrosis 
in 13 /17 cases and severe fibrosis in 1/17 cases. 1/17 was inconclusive. 
  
Picture 12 : Muscle fibrosis  
4. Perivascular fibrosis: There was mild fibrosis in 6/17 cases, moderate 
fibrosis in 8 /17 cases and severe fibrosis in 3/17 cases. 
 
Picture 13: Perivascular fibrosis 
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5. Elastic fibres:  There were absent in 2 /17 cases, rare in 5 /17 cases,  Few in   
6/17 cases and Many in 3 /17 cases and inconclusive in 1/17 cases.  
 
Picture 14: Elastic fibres 
6. Eosinophil: They are absent in all the cases. 
7. Macrophages: Few macrophages were seen in 1/17 cases. 
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8. Lymphocytes: Few lymphocytes were seen in 1/17 cases. 
9. Mast cells: They were absent in 1 /17 cases, rare in 8 /17 cases, few in 4/17 
cases and many in 4 /17 cases. 
 
Picture 14: Mast cells 
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Electron microscopy :  
1. Fibrosis of the peri-muscular connective tissue was noted.    
 
Picture 15A: Fibrosis in the perimucular connective tissue of the esophagus smooth muscle  
 
Picture 15B : Fibrosis in the perimuscular connectiv tissue at the lower esophageal 
sphincter.   
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2. Fibrosis of muscle fibres were noted.    
 
Picture 16A: Fibrosis of muscle layer - Mild 
 
 
Picture 16B : Fibrosis of muscle layer  - Severe 
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3. Demyelination of the nerve bundles were noted suggesting primary neuronal 
injury.   
 
   Picture 17A  : Normal myelinated nerve  
 
Picture 17B : Demyelinated nerve fibre  
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4. Degenerated pre-ganglionic and post-ganglionic nerve fibres. 
  
Picture 18A: Degenerated of pre-ganglionic nerve fibres  
  
Picture 18B: Degenerated of post-ganglionic nerve fibres 
71 
 
        
5. Eosinophils  were noted 
 
Picture 19: Eosinophils 
6. Mast cells were noted 
 
Picture 20: Mast cells. 
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Demography and other clinical results 
Age distribution:  
The patients were divided into three groups according to age. Achalasia was noted 
commonly in the 20 to 50 age group.  The disease can occur in age group but onset 
before adolescence is rare.  
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Male to female distribution:  
It was noted to be more common in females though in many studies they were noted 
to be equal in both genders.  
16
5
Male to Female distribution (n - 21)
Female
Male
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Duration of symptoms:  
Approximately 50% of the patients presented with 5 years of onset of symptoms.  
Earliest was at 4 months duration and longest was 15 years duration of illness. 
3, 14%
10, 48%
6, 29%
2, 9%
Duration of symptoms (n - 21)
<1 yr
 1-5 yrs
5-10 yrs
>10 yrs
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Dysphagia score:  
Mellows and Pinhas scoring system. Majority of the patients had dysphagia score of 4.   
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Regurgitation and chest pain:  
Majority of the patients did not have regurgitation.   Only a minority of them had 
chest pain 
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Vomiting and weight loss:   
Vomiting was noted in many of our patients.  Weight loss is noted in approximately 
half of them.  
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Pre-operative pneumatic dilatation:  
Seven of our patients had undergone balloon dilatation and 4 patients had undergone 
multiple dilatations.    
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Upper GI scopy and Barium esophagogram:  
Upper GI scopy was done in all the patients.  Barium esophagogram is done in 
majority of the patients.   
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High resolution manometry:  
Manometry was done in twenty patients. Except in one patient who had a 
megaesophagus. There were also logistic reasons for not being able to get the test 
done.  
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Intra-operative data  
Esophageal thickness:  
 
 
 
 
 
 
 
 
 
82 
 
Mucosal injury: 
Mucosal injury was encountered in three patients and it was repaired primarily. Leak 
test was not done routinely for all patients.   
Mucosal injury (n -21 
Yes
No
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Fundoplication:  
All the patients underwent anterior Dor’s fundoplication.  
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NG tube and abdominal drain placement:  
Seventeen patients underwent nasogastric tube placement.  
 
 
 
85 
 
Post-operative data :  
NG tube removal and initiation of feeds  
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Duration of hospital stay and post-operative 
dysphagia score:  
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Comparative analysis:  
Post-operative dysphagia score vs. age and sex 
  
 
 
 
 
It is clear that the patient with age less than 40 had better post-operative relief of 
dysphagia and women have better relief than men after the operation.  
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Duration of illness vs. ganglion cells and fibrosis:  
Ganglion cells decreases with increasing duration of illness  
 
Similarly, histopathological evidence of Fibrosis was noted to be increasing with 
prolonged duration of illness, of more than one year.  
 
 
                    
 
 
3 3
4
7
0
1
2
3
4
5
6
7
8
Upto 1 year of illness >1 year of illness
mild fibrosis
moderate to severe
fibrosis
n = 17
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Duration of illness vs. inflammation and nerve bundle hypertrophy:  
There is no difference in nerve bundle hypertrophy with duration of illness. (n - 15) 
 
There was no difference in the presence of inflammatory cells with durarion(n-15)  
2
7
2
4
0
1
2
3
4
5
6
7
8
Upto 1 year > 1 year
Lymphocytes -
present
Lymphocytes -
Absent
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Type of achalasia and fibrosis: 
The extent of fibrosis and the density of ganglion cells did not show any variation in 
the two manometric types of Achalasia 
 
 
 
 
 
 
 
 
 
 
 
1
4
2
10
0
2
4
6
8
10
12
Achalasia type I Achalasia type II
Fibrosis - Mild
Fibrosis - Mod to severe
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Type of Achalasia and mast cells:  
In Achalasia type II, mast cells were found in 92% of the patients.  
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Mast cells and fibrosis:  Severity of fibrosis and density of mast cells seem to 
have a linear relationship 
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           Discussion  
                             Achalasia cardia is an uncommon disease with unknown aetiology. 
As the specific inciting factor is unknown, the therapeutic options available for this 
disease is palliative.   
                           Analysis of the clinical parameters showed a female predilection 
(76%).  Sixty seven percent of our patients fell between 20 to 50 years of age group.  
Predominant symptom pre-operatively was dysphagia.  Median dysphagia score was 
4. Natural progression of the disease varies quite dramatically. Some patients 
presented as early as 4 months of onset of symptoms and some present after 15 years 
of onset of symtoms with recent worsening.  The reason for such a diverse 
presentation cannot be explained.  Sensory symptom like chest pain was noted only in 
9% of the study population. This explains that in achalasia, both sensory and motor 
neurons are affected.  Eighty percent of our patients were of achalasia type II with 
Median LES pressure of 35mmHg. Barium esophagogram revealed absent of primary 
peristalsis in 80% patients.  Esophageal diameter could not be assessed as this was a 
dynamic study.   
                          Intra-operatively, thickening of the esophageal muscle was noted in 
42% of patients, probably secondary to chronic obstruction.  All the patient underwent 
modified Heller’s myotomy done by either of the two well experienced surgeons. The  
extent of dissection, length of myotomy, method of tissue procurement for biopsy and 
type of fundoplication were similar between the two surgeons.  All the samples were 
processed by standardised technique and reported by an experienced pathologist. 
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                                         In our study, we noted loss of ganglion cells in majority of 
our patients. Loss of ganglion cells were more pronounced with the duration of illness. 
Patients with duration of illness more than 5 years, ganglion cells were noted only in 
12%. Overall, ganglion cells were lost in 72% of our patients.  This was consistent 
with the studies published by Goldblum et al.  
                                         As achalasia was thought to an inflammatory disease and the 
ganglion cells are lost secondary to inflammation, it was of great interest to us to study 
the inflammatory patterns. We did not find any significant evidence of inflammation 
in light microscopy.  However, immunohistochemistry revealed CD3 positivity 
lymphocytes in 8 of 14 patients (57%). This was in consistent with Villanci et al and 
Clark et al.   
                                        Electron microscopy did not show any evidence of on-going 
inflammation but there was fibrosis noted in the myentric plexus region, muscle and 
perimuscular and perivascular region.  This is consistent with the current 
understanding that the primary pathology is loss of myentric ganglia. Interestingly in 
one of our patient,   axonal degeneration of the nerve bundle involving both, 
myelinated nerve fibres and non-myelinated nerve fibres.  A cross-section at this level 
with myelinated and non-myelinated fibres would be intra-esophageal preganglionic 
vagal nerve fibres.  The changes noted could be due to the ‘dying back’ phenomenon 
of neuronal degeneration secondary to damage at the myentric plexus level.  Casella et 
al of mayo clinic(58) recorded similar feature in the electron microscope and they 
thought it could be due to wallerian degeneration of the nerve. They also found 
supporting evidence or morphological changes in the brain stem and dorsal motor 
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nucleus.  They thought achalasia is due to a central neuronal degeneration with 
peripheral manifestation in the esophagus rather than a primary pathology in the 
myentric plexus. Animal studies conducted with vagotomy have demonstrated 
changes mimicking achalasia but they were not consistent(59).  If it is a central 
degenerative disorder, like Casella et al inferred, one cannot explain myentric plexitis 
with loss of ganglion cell and fibrosis which are the consistent features in almost all 
the studies done so far. Moreover, patients with post-vagotomy done for acid 
reduction does not present with achalasia. 
                              We have also demonstrated eosinophil and mast cells favouring 
inflammation at the myentric plexus rather than central degeneration.  In patients with 
achalasia type II, 92% of them were noted to have mast cells.  Mast cells were of 
recent interest as they were noted to play a key role in the immunomodulation of the 
inflammatory diseases like inflammatory bowel disease, psoriasis, atropic dermatitis 
etc.(60).  Most of the mast cells were noted were noted to be in granulated state. This 
is in line with many of the non-allergic diseases,  where mast cells exhibit a 
phenomenon of ‘intragranular activation’ or ‘selective release’ of inflammatory 
mediators(60–62).  In Crohns disease,  mast cells in the smooth muscles region have 
be proven to modulate fibroblastic activity and influence hypertrophic and fibrotic 
response to inflammation(63).  
                               It was interesting to see eosinophils in a few patients.  Though 
eosinophils are commonly seen in the submucosal region of the gastro-intestinal tract, 
it is usually devoid in the esophagus(64). Presence of eosinophils suggests 
chemotactic entry to the myentric plexus region secondary to inflammation. Like, 
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mast cells, eosinophils are related to the inflammatory process in disease like 
ulcerative colitis. In fact it was thought to aid in the repair of inflammation and 
directly by activation of fibroblasts resulting in fibrosis of smooth muscles(65).  
                           Fibrosis was noted in majority of our patients. In patients with 
duration of illness more than one year, 70 % of them revealed fibrosis. There was no 
difference in the degree of fibrosis or the absence of ganglion cells between achalasia 
type I and II. Post-operative dysphagia relief was no influenced by the degree of 
fibrosis as the median dysphagia score was almost equal between patients with mild 
fibrosis and moderate to severe fibrosis.  
                             Women were noted to have better post-operative outcome compared 
with men. Patients with younger age(less than 40 years) were noted to have better 
dysphagia relief.  Lower esophgeal sphincter pressure more than 30mmHg was a 
known positive predictive factor, however in our study we did not find LES pressure 
or the type of achalasia, influencing post-operative outcomes. 3 /21 patients had 
mucosal perforation. One of which had endoscopic balloon dilatation done 5 times 
prior to the operation. .  Fundoplication did not have an impact of the dysphagia  and 
85% of the patient did not have symptoms of reflux disease following fundoplication.     
                              Nasogastric tube was inserted in 17/21 patients. Patients with 
nasogastric tube inserted had delayed initiation of oral feeds by one day and  their 
hospital stay extended by one day. Overall, there was delay in initiation of oral feeds 
and increase in the number of hospital stay compared to other centres. In our centre 
we do not routinely do leak test or intra-operative endoscopy which could explain the 
delay in onset of feeds.  As many of our patients were from West-Bengal and North 
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eastern parts of India, they have very poor support systems outside the hospital, so we 
tend to keep them in hospital longer than required which could explain the increased 
hospital stay. Otherwise there was no wound infection or leak in any of these patients.  
    Therapeutically implications drawn from our study is that onset of fibrosis was 
noted as early as 3 months of the onset of symptoms. This probably implies that the 
therapeutic window is quite short even if we know the incting factors of inflammation.  
In view of axonal injury with preservation of myelin and shwann cells, there is a 
theoretical possibility of neural regeneration.  Possibility of stem cell induction at the 
myentric plexus need evaluation.  Further evaluation with animal studies could 
probably shed more light in the pathophysiology of the disease.  
 
     Limitations 
1. Observations made cannot be validated for statistical significance as the sample 
size is less.  
2. Post-operative dysphagia score is a subjective measure.  Objective evidence of 
drop in lower esophageal pressure with manometry is not documented.  
3. Unequal distribution of achalasia type I and type II  
4. Effect of fundoplication of acid reflux can be assessed only by pH monitoring 
as patients with achalasia have decreased sensation.  
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Conclusion 
1. Achalasia cardia is an inflammatory disease of the myentric plexus with early 
onset of fibrosis and progressive  neuronal degeneration affecting myelinated and 
non-myelinated neurons. 
2. Degree of fibrosis increases with the duration of illness.    
3. Degree of fibrosis of the lower esophageal sphincter or degree of inflammation in 
the myentric plexus did not affect the manometric features of dysphagia or post-
operative outcomes.  
4. Selective inhibition of the inhibitory neurons and inciting factors are the facets of 
the disease which still remains an enigma.   
5. Mast and eosinophils  may play a key role in fibrosis.   
6. Pathophysiology of this disease needs further evaluation.  In view of intact myelin 
and shwann cells in many of the degenerated nerves, whether axonal regeneration 
and stem cell therapy for loss of ganglion cells will bring back the peristalsis of 
the esophagus is a question which can be addressed with animal studies.   
7. If the molecular mechanism of mast cell and eosinophil’s role is the disease could 
be demystified, targeted therapy can be possible by immunomodulation.   
8. Positive predictive factors for dysphagia relief are younger age group and women. 
Type of achalasia, lower esophageal sphincter pressure, degree of fibrosis, density 
of ganglion cells or duration of illness have no influence on the post-operative 
outcomes.  
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9.  Seven centimetre cardiomyotomy have adequate dysphagia relief.  
10.  Anterior fundoplication associated with modified Heller’s myotomy did not 
influence dysphagia following the operation.  
11.  Insertion of nasogastric tube delays the onset of oral nutrition following surgery 
and prolongs the hostpital stay. 
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